Artificial Intelligence

Pathomation continues their series on software development. The earlier parts are available here: Part 1: Processes to facilitate a software development life cycle Part 2: The need for software validation In this episode, we want...

July 28, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), for patients with multiple architectural distortion (AD) identified on digital breast tomosynthesis (DBT), biopsy of all areas may be warranted, given...

VistaPath & Gestalt: Joining Forces to Create New AI Capabilities in the Pathology Lab CAMBRIDGE, Mass., July 28, 2022 /PRNewswire/ -- VistaPath, the leading provider of artificial intelligence (AI)-based, data-driven pathology...

SINGAPORE, July 29, 2022 /PRNewswire/ -- HistoIndex, a global leading artificial intelligence digital pathology (AI-DP) provider, announced that its AI-based qFibrosis®, qSteatosis® and qBallooning® algorithms delivered sensitivity and...

SAN JOSE, Calif., July 28, 2022 /PRNewswire/ -- OptraSCAN® a leading end-to-end digital pathology solution provider, announced that it has received CE-IVDR marking for the OS-Ultra™ scanners, its high-performance product line of...

[SEOUL, South Korea, Jul. 21, 2022] Lunit, a global provider of AI-powered cancer solutions, announced today that it made its stock market debut on the South Korean KOSDAQ under the ticker “A32813”. Lunit’s initial public offering of...